A Double-blinded, Randomized, Placebo-Controlled Phase III Study to assess the efficacy of reMAGE-A3 + AS15 ASCI as Adjuvant therapy in Patients with MAGE-A3 Positive Resected Stage III Melanoma
|Effective start/end date||7/31/08 → 7/31/13|
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.